NewAmsterdam Pharma NAMS
NASDAQ NAMS
$24.16 -0.16 (-0.66%)
At close: Oct 1, 2026 · 4:00 PM EDT

NewAmsterdam Pharma (NAMS) Shares Outstanding (Entity) (2021 - 2026)

Updated

NewAmsterdam Pharma's Shares Outstanding (Entity) was 117.65 million in Q2 2026, up 4.6% from 112.51 million a year earlier and up 0.9% from the prior quarter.

Analysis

NewAmsterdam Pharma (NAMS) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends

For FY2025, Shares Outstanding (Entity) at NewAmsterdam Pharma came in at 114.4 million, up 5.9% from FY2024.

  • Shares Outstanding (Entity) has now increased for five consecutive years, with a five-year compound annual growth rate of 60.8% (FY2020 to FY2025).
  • In earlier years, Shares Outstanding (Entity) was 108.06 million in FY2024 (+31.0%), 82.47 million in FY2023 (+1.1%), 81.56 million in FY2022 (+238.0%) and 24.13 million in FY2021 (+126.5%).
  • The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2021.
  • Compared with a year earlier, Shares Outstanding (Entity) has increased for 11 straight quarters, with growth averaging 16.3% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 1.1% in Q4 2023 to 238.0% in Q4 2022.
  • Per Business Quant data, NAMS's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 116.64 million (Q1 2026), 114.4 million (Q4 2025) and 113.17 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 NewAmsterdam Pharma 2.86 Bn 2.86 Bn - 117.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.65 Mn
Mar 31, 2026 116.64 Mn
Dec 31, 2025 114.40 Mn
Sep 30, 2025 113.17 Mn
Jun 30, 2025 112.51 Mn
Mar 31, 2025 112.17 Mn
Dec 31, 2024 108.06 Mn
Sep 30, 2024 92.17 Mn
Jun 30, 2024 90.02 Mn
Mar 31, 2024 89.72 Mn
Dec 31, 2023 82.47 Mn
Sep 30, 2023 82.47 Mn
Jun 30, 2023 82.32 Mn
Mar 31, 2023 81.77 Mn
Dec 31, 2022 81.56 Mn
Dec 31, 2021 24.13 Mn
API Access

NewAmsterdam Pharma Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=NAMS&period=max&api_key=YOUR_API_KEY